Real-time enrollment status for this lung cancer clinical trial
Current Status
Unknown
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT03797391 |
| Recruiting Status | Unknown |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 186 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Shanghai EpimAb Biotherapeutics Co., Ltd. |
| Last Updated on CT.gov | May 31, 2023 (May 31, 2023) |
As of March 2, 2026: Clinical trial NCT03797391 is currently unknown participants. This clinical trial study for lung cancer is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Shanghai EpimAb Biotherapeutics Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03797391 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03797391 was last updated May 31, 2023 (May 31, 2023). HelloStudys verifies this status automatically.